Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.250
-0.010 (-0.79%)
Jan 22, 2026, 12:58 PM EST - Market open
Sunshine Biopharma Revenue
Sunshine Biopharma had revenue of $9.42M in the quarter ending September 30, 2025, with 11.64% growth. This brings the company's revenue in the last twelve months to $37.32M, up 13.24% year-over-year. In the year 2024, Sunshine Biopharma had annual revenue of $34.87M with 44.75% growth.
Revenue (ttm)
$37.32M
Revenue Growth
+13.24%
P/S Ratio
0.12
Revenue / Employee
$717,764
Employees
52
Market Cap
6.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.87M | 10.78M | 44.75% |
| Dec 31, 2023 | 24.09M | 19.75M | 454.42% |
| Dec 31, 2022 | 4.35M | 4.12M | 1,802.41% |
| Dec 31, 2021 | 228.43K | 157.02K | 219.88% |
| Dec 31, 2020 | 71.41K | 50.29K | 238.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Flora Growth | 57.61M |
| IM Cannabis | 37.61M |
| Biofrontera | 37.16M |
| cbdMD | 19.19M |
| Sonoma Pharmaceuticals | 16.94M |
| RedHill Biopharma | 9.55M |
| InMed Pharmaceuticals | 4.80M |
| China Pharma Holdings | 4.05M |
SBFM News
- 3 months ago - Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM) - Accesswire
- 3 months ago - Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea - Accesswire
- 3 months ago - Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline - Accesswire
- 3 months ago - Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin - Accesswire
- 3 months ago - Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM) - Accesswire
- 3 months ago - Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM) - Accesswire
- 3 months ago - Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience - Accesswire
- 3 months ago - Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections - Accesswire